• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝门部移植后淋巴组织增生性疾病导致肝动脉狭窄和胆汁淤积

Post-Transplant Lymphoproliferative Disorder at the Porta Hepatis Causing Hepatic Artery Stenosis and Cholestasis.

作者信息

Rawashdeh Badi, Papageorge Christina, Al-Adwan Yazan

机构信息

Division of Transplant Surgery, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA.

Division of Transplant Surgery, Department of Surgery, University of Virginia School of Medicine, UVA Health, Charlottesville, VA, USA.

出版信息

Am J Case Rep. 2025 Jan 23;26:e945837. doi: 10.12659/AJCR.945837.

DOI:10.12659/AJCR.945837
PMID:39844443
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11774434/
Abstract

BACKGROUND Post-transplant lymphoproliferative disorder (PTLD) encompasses a group of disorders ranging from hyperplastic to malignant lymphoid proliferations in the post-transplant period owing to immunosuppression, often in the setting of EBV transformation. PTLD is a rare complication of immunosuppression that, like lymphomas, can have a variable presentation based on disease localization. We report a case of PTLD mass effect at the porta hepatis for the first time in the literature, resulting in hepatic artery stenosis (HAS) and common hepatic duct obstruction. CASE REPORT A 54-year-old woman presented with cholestasis 4 months after receiving a deceased donor liver transplant. MRCP revealed a mass at the porta hepatis causing biliary compression, which resolved with subsequent biliary stenting. The woman presented again 3 weeks later with a similar presentation. CT revealed that the mass had enlarged, causing HAS, which resolved with subsequent hepatic artery stenting. The biopsy revealed PTLD, and the patient was successfully managed with rituximab and a reduction of her immunosuppressive regimen. CONCLUSIONS This case report describes a rare occurrence of PTLD, which particularly impacting the porta hepatis, resulting in HAS and compression of the bile duct. PTLD should be considered in the differential diagnosis for obstructive jaundice and hepatic artery compression, even in the early post-transplant months, when these symptoms are often attributed to surgical factors.

摘要

背景 移植后淋巴组织增生性疾病(PTLD)包括一组在移植后由于免疫抑制(通常在EBV转化的情况下)而发生的从增生性到恶性淋巴样增生的疾病。PTLD是免疫抑制的一种罕见并发症,与淋巴瘤一样,其临床表现会因疾病定位的不同而有所变化。我们首次在文献中报道了一例发生于肝门部的PTLD肿块效应,导致肝动脉狭窄(HAS)和肝总管梗阻。病例报告 一名54岁女性在接受已故供体肝脏移植4个月后出现胆汁淤积。磁共振胰胆管造影(MRCP)显示肝门部有一肿块导致胆管受压,随后通过胆管支架置入,症状缓解。3周后该女性再次出现类似症状。CT显示肿块增大,导致肝动脉狭窄,随后通过肝动脉支架置入,症状缓解。活检显示为PTLD,患者通过利妥昔单抗治疗及减少免疫抑制方案而成功治愈。结论 本病例报告描述了一种罕见的PTLD病例,其特别影响肝门部,导致肝动脉狭窄和胆管受压。即使在移植后的早期数月,当这些症状常被归因于手术因素时,在梗阻性黄疸和肝动脉受压的鉴别诊断中也应考虑PTLD。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7db9/11774434/7445f8b4aa83/amjcaserep-26-e945837-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7db9/11774434/56c3960e87e4/amjcaserep-26-e945837-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7db9/11774434/200aefbf83e6/amjcaserep-26-e945837-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7db9/11774434/7445f8b4aa83/amjcaserep-26-e945837-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7db9/11774434/56c3960e87e4/amjcaserep-26-e945837-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7db9/11774434/200aefbf83e6/amjcaserep-26-e945837-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7db9/11774434/7445f8b4aa83/amjcaserep-26-e945837-g003.jpg

相似文献

1
Post-Transplant Lymphoproliferative Disorder at the Porta Hepatis Causing Hepatic Artery Stenosis and Cholestasis.肝门部移植后淋巴组织增生性疾病导致肝动脉狭窄和胆汁淤积
Am J Case Rep. 2025 Jan 23;26:e945837. doi: 10.12659/AJCR.945837.
2
Robotic Biliary Stricturoplasty and Roux-en-Y Hepaticojejunostomy After Hepatic Artery Infusion Pump Injury.机器人胆道狭窄成形术和 Roux-en-Y 肝肠吻合术治疗肝动脉灌注泵损伤。
Ann Surg Oncol. 2024 Jul;31(7):4449-4451. doi: 10.1245/s10434-024-15258-0. Epub 2024 Apr 17.
3
Post-transplant lymphoproliferative disorder of the pediatric airway: Presentation and management.小儿气道移植后淋巴组织增生性疾病:临床表现与管理
Int J Pediatr Otorhinolaryngol. 2016 Jul;86:218-23. doi: 10.1016/j.ijporl.2016.04.035. Epub 2016 Apr 30.
4
Post-Transplant Lymphoproliferative Disorder (PTLD) Manifesting in the Oral Cavity of a 13-Year-Old Liver Transplant Recipient (LTx).一名13岁肝移植受者口腔出现的移植后淋巴细胞增生性疾病(PTLD)
Ann Transplant. 2015 Aug 18;20:478-82. doi: 10.12659/AOT.893497.
5
[Early diagnosis and comprehensive treatments of post-transplantation lymphoproliferative disorder after pediatric liver transplantation].小儿肝移植术后移植后淋巴细胞增生性疾病的早期诊断与综合治疗
Zhonghua Er Ke Za Zhi. 2014 Aug;52(8):579-82.
6
Hepatic artery stenosis in liver transplant recipients: prevalence and cholangiographic appearance of associated biliary complications.肝移植受者的肝动脉狭窄:相关胆道并发症的发生率及胆管造影表现
AJR Am J Roentgenol. 1995 Nov;165(5):1145-9. doi: 10.2214/ajr.165.5.7572493.
7
[Post-transplant lymphoproliferative disease in liver transplant recipients--Merkur University Hospital single center experience].[肝移植受者的移植后淋巴细胞增生性疾病——梅尔库大学医院单中心经验]
Acta Med Croatica. 2011 Sep;65 Suppl 1:37-43.
8
Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience.成人肝移植受者移植后淋巴组织增生性疾病:一项南美洲多中心经验。
Clin Transplant. 2013 Jul-Aug;27(4):E469-77. doi: 10.1111/ctr.12152. Epub 2013 Jun 13.
9
Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.小儿肝移植受者淋巴增殖性疾病的多种临床表现:单中心经验
Transplant Proc. 2010 Jun;42(5):1763-8. doi: 10.1016/j.transproceed.2010.01.077.
10
Use of radiation therapy in posttransplant lymphoproliferative disorder (PTLD) after liver transplantation.放射治疗在肝移植后移植后淋巴细胞增生性疾病(PTLD)中的应用。
Int J Cancer. 2000 Apr 20;90(2):104-9. doi: 10.1002/(sici)1097-0215(20000420)90:2<104::aid-ijc6>3.0.co;2-0.

本文引用的文献

1
Global research productivity of post-transplant lymphoproliferative disorder: a bibliometric study.移植后淋巴细胞增生性疾病的全球研究生产力:一项文献计量学研究。
Ann Med Surg (Lond). 2024 Feb 5;86(3):1522-1530. doi: 10.1097/MS9.0000000000001771. eCollection 2024 Mar.
2
Post-transplantation Lymphoproliferative Disorder (PTLD): In the Liver Transplant Recipient.移植后淋巴细胞增生性疾病(PTLD):肝移植受者中的情况
J Clin Exp Hepatol. 2024 Mar-Apr;14(2):101286. doi: 10.1016/j.jceh.2023.09.007. Epub 2023 Sep 20.
3
Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder.
成人移植后淋巴细胞增生性疾病的最新进展
Cancers (Basel). 2022 Dec 1;14(23):5949. doi: 10.3390/cancers14235949.
4
Gastrointestinal manifestations, risk factors, and management in patients with post-transplant lymphoproliferative disorder: A systematic review.移植后淋巴细胞增生性疾病患者的胃肠道表现、危险因素及管理:一项系统综述
World J Transplant. 2022 Aug 18;12(8):268-280. doi: 10.5500/wjt.v12.i8.268.
5
Percutaneous Transarterial Stent Placement in a Transplant Liver Hepatic Artery Complicated by Angioplasty Balloon Rupture and Fragmentation.经皮经动脉支架置入术治疗移植肝肝动脉并发血管成形术球囊破裂及碎片残留
Semin Intervent Radiol. 2019 Jun;36(2):133-136. doi: 10.1055/s-0039-1688428. Epub 2019 May 22.
6
Post-transplantation lymphoproliferative disorder with gastrointestinal involvement.伴有胃肠道受累的移植后淋巴细胞增生性疾病
Ann Gastroenterol. 2018 Mar-Apr;31(2):248-251. doi: 10.20524/aog.2018.0226. Epub 2018 Jan 8.
7
Post-transplant cholangiopathy: Classification, pathogenesis, and preventive strategies.移植后胆管病:分类、发病机制和预防策略。
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1507-1515. doi: 10.1016/j.bbadis.2017.06.013. Epub 2017 Jun 20.
8
Post-transplant lymphoproliferative disorder after liver transplantation: Incidence, long-term survival and impact of serum tacrolimus level.肝移植后移植后淋巴组织增生性疾病:发病率、长期生存率及血清他克莫司水平的影响
World J Gastroenterol. 2017 Feb 21;23(7):1224-1232. doi: 10.3748/wjg.v23.i7.1224.
9
Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders.浆细胞骨髓瘤和浆细胞瘤样移植后淋巴细胞增生性疾病的生存分析与预后
Clin Lymphoma Myeloma Leuk. 2016 Dec;16(12):684-692.e3. doi: 10.1016/j.clml.2016.09.002. Epub 2016 Sep 17.
10
Intention-to-treat analysis of percutaneous endovascular treatment of hepatic artery stenosis after orthotopic liver transplantation.原位肝移植术后肝动脉狭窄经皮血管腔内治疗的意向性分析。
Liver Transpl. 2016 Jul;22(7):923-33. doi: 10.1002/lt.24468.